Acute Isolated Thrombocytopenia Secondary to Meloxicam Use: A Case Report
Grand Strand Medical Center
bleeding disorders, nsaids, isolated thrombocytopenia, drug-induced thrombocytopenia, meloxicam, drug-related side effects and adverse reactions
Hemic and Lymphatic Diseases | Internal Medicine
Meloxicam is a widely used nonsteroidal anti-inflammatory drug (NSAID) that is used to treat pain and some inflammatory disorders. One rare side effect is drug-induced thrombocytopenia (DITP), which can result in hemorrhage and death if not treated urgently. This diagnosis can be missed if mistaken for other conditions such as ITP, which is problematic since the mainstay of treatment is medication cessation. We present a case of a 42-year-old Hispanic female who was recently started on meloxicam and presented with petechiae, ecchymosis, and a platelet count of 2 (normal 150-350 K/mm3).
Publisher or Conference
Abdelsayed N, Frost M, Betz WR. Acute Isolated Thrombocytopenia Secondary to Meloxicam Use: A Case Report. Cureus. 2022;14(1):e21232. doi:10.7759/cureus.21232